Which TKI Should Be Recommended as Initial Treatment for CML in Chronic

Which TKI Should Be Recommended as Initial Treatment for CML in Chronic

Filed under: drug treatment news articles

Approximately 60% of newly diagnosed CML patients will remain in complete cytogenetic remission and continuing on imatinib 5+ years after treatment is begun, with an extremely low rate of relapse if they continue to take the drug.[1] Some patients will …
Read more on Cancer Network

 

Treating Equine Canker with Topical Cisplatin Chemotherapy

Filed under: drug treatment news articles

Canker, a destructive inflammatory disease of the hoof that generally originates in the frog, has always frustrated treating veterinarians. Typical treatments include superficial debridement, topical therapies such as the antimicrobial drug …
Read more on TheHorse.com

 

ImmunoGen Is Living Life in the Fast Lane

Filed under: drug treatment news articles

One of those stories emerged Tuesday when ImmunoGen (Nasdaq: IMGN ) and partner Roche (NASDAQOTH: RHHBY) announced that T-DM1, their experimental drug to treat HER2-positive breast cancer, has been awarded a priority review by the Food and Drug …
Read more on Motley Fool